Tel: 01789 267520

Latest News: Research

New Clinical Care Research Article: End Of Life Care

12 August 2016 / Posted in: Research

In this article, Dr. Alex Murphy describes the sensitivity of discussions around 'end of life care'. He also introduces some of the studies that have been carried out to examine the effectiveness of palliative care.

Read full story

Biogen and Ionis Pharmaceuticals' Statement re Nusinersen Announcement

02 August 2016 / Posted in: Research

Biogen and Ionis Pharmaceuticals have announced that Nusinersen has met the primary endpoint in an interim analysis of the phase 3 ENDEAR Study in infants with Infantile-Onset SMA.

Read full story

AVXS-101 Receives “Breakthrough Therapy Designation”

28 July 2016 / Posted in: Research

The US Food and Drug Administration (FDA) has granted “Breakthrough Therapy” status to AVXS-101, a gene therapy drug with future potential to treat SMA.

Read full story

AAV Therapies report in MDUK’s latest edition of ‘Target Research’

07 July 2016 / Posted in: Research

Dr Haiyan Zhou discusses how gene therapy using harmless viruses called AAVs has great potential as a therapeutic approach to replace defective genes that are responsible for conditions such as SMA and Duchenne muscular dystrophy.

Read full story

Can you help identify what questions scoliosis research needs to answer?

30 June 2016 / Posted in: Research

The Scoliosis Research Priority Setting Partnership wants to hear the views of people of all ages with scoliosis, their family, friends and health professionals.

Read full story

UK and US Research Interview Study

20 June 2016 / Posted in: Research

The study is looking for participants to help increase understanding of the lived experience of SMA. It aims to support pharmaceutical companies with their research relating to potential treatments in SMA and increase the knowledge of SMA amongst the wider scientific community.

Read full story

Novartis Drug Safety Concerns Reported

02 June 2016 / Posted in: Research

Safety concerns have prompted the pharmaceutical company Novartis to pause enrolment in the Phase 2 clinical trial of their SMN2 splice-modifying drug LMI070.

Read full story

New Clinical Care Research Article: Medications Research Review

26 May 2016 / Posted in: Research

Dr. Alex Murphy, our Clinical Care Research Correspondent, looks at medications that target other conditions that have been investigated as a treatment for Spinal Muscular Atrophy.

Read full story

Avexis Provides Update on Viral Gene Therapy Trial

23 May 2016 / Posted in: Research

At two separate conferences in the USA in May, Avexis has presented the latest data from the ongoing Phase 1 clinical trial of their gene therapy drug for SMA, AVXS-101.

Read full story

Revisiting The Consensus Statement For Standards Of Care In SMA

11 May 2016 / Posted in: Research

In February this year, clinical researchers and patient representatives from Europe and the US met to start work on the major review of the International Standards of Care for SMA.

Read full story